Global Disodium Ribonucleotides (I+G) Market Strategic Research Report
By Type: GMP, IMP, I+G Type
By Application: MSG and Chicken Essence, Soy Sauce, Instant Noodle Seasoning Packet, Seasoning Compound Sauce, Others
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: CJ Group, Ajinomoto, Meihua Group, Star Lake Bioscience, Daesang, Foison Biotechnology
概観
Scope of the Report
The global Disodium Ribonucleotides (I+G) market size is predicted to grow from US$ 636 million in 2025 to US$ 798 million in 2032; it is expected to grow at a CAGR of 3.5% from 2026 to 2032.
Disodium Ribonucleotides (I+G), commonly known as I+G, is a high-efficiency flavor enhancer composed mainly of disodium inosinate (IMP) and disodium guanylate (GMP). It enhances umami taste by synergistically interacting with monosodium glutamate (MSG), providing stronger flavor intensity with lower usage levels. Disodium Ribonucleotides (I+G) is widely used in food seasoning applications, including MSG and chicken essence, soy sauce, instant noodle seasoning packets, compound seasoning sauces, and other processed food products. This research focuses on Disodium Ribonucleotides (I+G) products with different composition structures, including GMP, IMP, and I+G blended products, covering their production, supply, and application across the global food ingredient market.
Key Findings
Global Disodium Ribonucleotides (I+G) sales reached 75,006 MT in 2025
Average market price reached US$8,245 per MT in 2025
China accounted for 54.10% of global market demand in 2025
Southeast Asia represented 31.66% of global market demand
Top five players accounted for 91.09% of global revenue
Market Trends
The Disodium Ribonucleotides (I+G) industry is moving from a technology introduction stage toward refined operation and global competition. Demand is increasingly influenced by changes in food consumption patterns, including the expansion of ready-to-eat meals, snacks, plant-based foods, and convenience food products. Food manufacturers are also paying greater attention to flavor optimization, sodium reduction solutions, and clean-label product development, which is supporting the continued adoption of Disodium Ribonucleotides (I+G) as an efficient umami enhancer. At the same time, manufacturers are strengthening production efficiency, quality consistency, and customized formulation capabilities to improve competitiveness in a mature market.
Market Dynamics
Drivers
The growth of Disodium Ribonucleotides (I+G) demand is primarily driven by the expansion of processed food consumption, increasing penetration of global chain restaurants, and rising demand for convenient food products. The growth of ready-to-eat meals, instant food, snacks, and compound seasonings continues to create stable application opportunities. In addition, consumers’ preference for reduced-sodium foods without sacrificing taste is strengthening the strategic importance of Disodium Ribonucleotides (I+G), as it can enhance umami intensity and support lower salt formulations.
Restraints
The Disodium Ribonucleotides (I+G) market faces limitations from its relatively mature application structure and high dependence on downstream seasoning industries. Although demand remains stable, market expansion is closely linked to the growth rate of processed foods and foodservice sectors. In addition, strict food safety requirements, quality consistency standards, and production technology barriers increase operational requirements for manufacturers.
Opportunities
Emerging markets, particularly Southeast Asia and Africa, provide additional growth opportunities due to increasing per capita condiment consumption and expansion of processed food industries. The continued development of ready-to-eat meals, plant-based foods, and premium seasoning products creates new application scenarios for Disodium Ribonucleotides (I+G).
Challenges
The Disodium Ribonucleotides (I+G) industry faces challenges from high market concentration, intensified competition among leading producers, and pressure to maintain cost competitiveness. As China has become the global production center with more than 70% of global I+G production capacity, competition is increasingly focused on production efficiency, supply chain advantages, and pricing strategies.
Industry Chain Analysis
The Disodium Ribonucleotides (I+G) industry chain consists of upstream raw materials, fermentation-based manufacturing, and downstream food applications. Upstream production mainly relies on agricultural and biological raw materials required for fermentation processes, while midstream manufacturers use microbial fermentation, extraction, purification, and blending technologies to produce GMP, IMP, and I+G products. Production efficiency, fermentation technology, quality control, and scale advantages determine cost competitiveness.
Segment Insights
The Disodium Ribonucleotides (I+G) market is mainly segmented by product type and application. I+G blended products represent the mainstream commercial form due to their strong synergistic umami enhancement effect when combined with MSG. GMP and IMP products serve as important raw materials for customized formulations and specific applications.
Downstream Market Opportunities
The downstream market for Disodium Ribonucleotides (I+G) is closely connected with the global food processing and seasoning industries. Traditional applications such as MSG, chicken essence, soy sauce, and instant noodle seasoning remain stable demand bases, while emerging categories including ready-to-eat meals, snacks, plant-based foods, and premium sauces are expanding application opportunities.
Competitive Landscape Analysis
The global Disodium Ribonucleotides (I+G) market demonstrates a highly concentrated oligopolistic competitive structure. Major participants include CJ Group, Ajinomoto, Meihua Group, Star Lake Bioscience, Daesang, and Foison Biotechnology. In 2025, the top five players accounted for approximately 91.09% of global revenue, reflecting strong concentration among leading producers. China has become the core global supply base, supported by fermentation capabilities, production scale, and integrated industrial chains.
This report presents a comprehensive overview of the global Disodium Ribonucleotides (I+G) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- GMP
- IMP
- I+G Type
Segment by Production Process
- Fermentation
- Enzymatic Conversion
- Semi-Synthesis
Segment by Product Form
- Powder
- Granules
- Crystals
Segment by Application
- MSG and Chicken Essence
- Soy Sauce
- Instant Noodle Seasoning Packet
- Seasoning Compound Sauce
- Others
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Disodium Ribonucleotides (I+G) market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in MSG and Chicken Essence, Soy Sauce, Instant Noodle Seasoning Packet evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Disodium Ribonucleotides (I+G) Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 GMP
- 3.1.3 IMP
- 3.1.4 I+G Type
- 3.1.5 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 MSG and Chicken Essence
- 4.1.3 Soy Sauce
- 4.1.4 Instant Noodle Seasoning Packet
- 4.1.5 Seasoning Compound Sauce
- 4.1.6 Others
- 4.1.7 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 CJ Group
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Ajinomoto
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Meihua Group
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Star Lake Bioscience
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Daesang
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Foison Biotechnology
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
How big is the global Disodium Ribonucleotides (I+G) market?
How fast is the Disodium Ribonucleotides (I+G) market expected to grow?
What does the Disodium Ribonucleotides (I+G) market cover?
How is the Disodium Ribonucleotides (I+G) market segmented by type?
What are the key applications of Disodium Ribonucleotides (I+G)?
Which companies are profiled in the Disodium Ribonucleotides (I+G) market report?
What geographies does the Disodium Ribonucleotides (I+G) market analysis include?
What are the key demand drivers for Disodium Ribonucleotides (I+G)?
What are the main risks and barriers in the Disodium Ribonucleotides (I+G) market?
Who should buy the Disodium Ribonucleotides (I+G) market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Disodium Ribonucleotides (I+G) Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Food & Beverages